Survival-associated heterogeneity of marker-defined perivascular cells in colorectal cancer
暂无分享,去创建一个
J. Mulder | F. Pontén | H. Sorbye | K. Pietras | E. Kure | E. Skovlund | T. Guren | B. Glimelius | T. Ikdahl | P. Pfeiffer | K. Tveit | A. Östman | C. Qvortrup | Maja Bradic Lindh | A. Mezheyeuski | Sara Corvigno | C. Strell | A. Dragomir | A. Portyanko
[1] G. Wisman,et al. Markers of fibroblast-rich tumor stroma and perivascular cells in serous ovarian cancer: Inter- and intra-patient heterogeneity and impact on survival , 2016, Oncotarget.
[2] Rakesh K. Jain,et al. Role of vascular density and normalization in response to neoadjuvant bevacizumab and chemotherapy in breast cancer patients , 2015, Proceedings of the National Academy of Sciences.
[3] F. Pontén,et al. High BRAF Mutation Frequency and Marked Survival Differences in Subgroups According to KRAS/BRAF Mutation Status and Tumor Tissue Availability in a Prospective Population-Based Metastatic Colorectal Cancer Cohort , 2015, PloS one.
[4] Claudia Maggi,et al. Predictive role of BRAF mutations in patients with advanced colorectal cancer receiving cetuximab and panitumumab: a meta-analysis. , 2015, European journal of cancer.
[5] R. Kalluri,et al. Targeting vascular pericytes in hypoxic tumors increases lung metastasis via angiopoietin-2. , 2015, Cell reports.
[6] Camille Stephan-Otto Attolini,et al. Stromal gene expression defines poor-prognosis subtypes in colorectal cancer , 2015, Nature Genetics.
[7] G. Inghirami,et al. Stromal contribution to the colorectal cancer transcriptome , 2015, Nature Genetics.
[8] T. Wieland,et al. RGS5 promotes arterial growth during arteriogenesis , 2014, EMBO molecular medicine.
[9] Yihai Cao,et al. Tumour PDGF-BB expression levels determine dual effects of anti-PDGF drugs on vascular remodelling and metastasis , 2013, Nature Communications.
[10] R. Kalluri,et al. Origin and function of myofibroblasts in kidney fibrosis , 2013, Nature Medicine.
[11] B. Berghuis,et al. Pericyte coverage of differentiated vessels inside tumor vasculature is an independent unfavorable prognostic factor for patients with clear cell renal cell carcinoma , 2013, Cancer.
[12] G. Eberl,et al. Lineage tracing and genetic ablation of ADAM12+ perivascular cells identify a major source of profibrotic cells during acute tissue injury , 2012, Nature Medicine.
[13] H. Sorbye,et al. Phase III trial of cetuximab with continuous or intermittent fluorouracil, leucovorin, and oxaliplatin (Nordic FLOX) versus FLOX alone in first-line treatment of metastatic colorectal cancer: the NORDIC-VII study. , 2012, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[14] Zainab N. Khan,et al. Pericyte depletion results in hypoxia-associated epithelial-to-mesenchymal transition and metastasis mediated by met signaling pathway. , 2012, Cancer cell.
[15] A. Bardelli,et al. Targeting oncogenic serine/threonine-protein kinase BRAF in cancer cells inhibits angiogenesis and abrogates hypoxia , 2011, Proceedings of the National Academy of Sciences.
[16] D. Hanahan,et al. Pericytes promote endothelial cell survival through induction of autocrine VEGF-A signaling and Bcl-w expression. , 2011, Blood.
[17] C. Betsholtz,et al. Pericytes: developmental, physiological, and pathological perspectives, problems, and promises. , 2011, Developmental cell.
[18] O. Shupliakov,et al. A Pericyte Origin of Spinal Cord Scar Tissue , 2011, Science.
[19] P. Stattin,et al. Stromal PDGFRβ Expression in Prostate Tumors and Non-Malignant Prostate Tissue Predicts Prostate Cancer Survival , 2010, PloS one.
[20] D. Schadendorf,et al. Resistance to antiangiogenic therapy is directed by vascular phenotype, vessel stabilization, and maturation in malignant melanoma , 2010, The Journal of experimental medicine.
[21] H. Sorbye,et al. Clinical trial enrollment, patient characteristics, and survival differences in prospectively registered metastatic colorectal cancer patients , 2009, Cancer.
[22] C. Kuo,et al. Cellular source and amount of vascular endothelial growth factor and platelet-derived growth factor in tumors determine response to angiogenesis inhibitors. , 2009, Cancer research.
[23] D. Sargent,et al. Patient characteristics and stratification in medical treatment studies for metastatic colorectal cancer: a proposal for standardization of patient characteristic reporting and stratification. , 2007, Annals of oncology : official journal of the European Society for Medical Oncology.
[24] L. Ellis,et al. Overexpression of PDGF-BB decreases colorectal and pancreatic cancer growth by increasing tumor pericyte content. , 2007, The Journal of clinical investigation.
[25] Ruud P. M. Dings,et al. Scheduling of Radiation with Angiogenesis Inhibitors Anginex and Avastin Improves Therapeutic Outcome via Vessel Normalization , 2007, Clinical Cancer Research.
[26] Bin Tean Teh,et al. Two Distinct Types of Blood Vessels in Clear Cell Renal Cell Carcinoma Have Contrasting Prognostic Implications , 2007, Clinical Cancer Research.
[27] Holger Gerhardt,et al. Pericytes limit tumor cell metastasis. , 2006, The Journal of clinical investigation.
[28] T. Sjöblom,et al. Platelet-derived growth factor production by B16 melanoma cells leads to increased pericyte abundance in tumors and an associated increase in tumor growth rate. , 2004, Cancer research.
[29] W. Scheithauer,et al. Clinical determinants of survival in patients with 5-fluorouracil-based treatment for metastatic colorectal cancer: results of a multivariate analysis of 3825 patients. , 2002, Annals of oncology : official journal of the European Society for Medical Oncology.
[30] B R Johansson,et al. Pericyte loss and microaneurysm formation in PDGF-B-deficient mice. , 1997, Science.
[31] A. McMahon,et al. Fate tracing reveals the pericyte and not epithelial origin of myofibroblasts in kidney fibrosis. , 2010, The American journal of pathology.
[32] D. Brenner,et al. Epithelial and Mesenchymal Cell Biology Pericytes and Perivascular Fibroblasts Are the Primary Source of Collagen-Producing Cells in Obstructive Fibrosis of the Kidney , 2010 .